Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2022

Dec 7, 2022

30786_dirs_2022-12-07_8ec92beb-f014-4c9b-939a-3a13615065f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-11-07

Reporting Person: SCHWARTZ STEVEN D (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-07 Bio-Rad B Common Stock G 42 $.00 Acquired 25128 Direct
2022-11-07 Bio-Rad B Common Stock G 42 $.00 Acquired 12900 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 1818.0335 Indirect
Bio-Rad A Common Stock 362146 Direct
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.